Ernesto Bernal-Mizrachi MD
Adrenal Disease, Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology
Chief, Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine
Join to View Full Profile
5555 Ponce de Leon BlvdCoral Gables, FL 33146
Phone+1 305-689-3636
Fax+1 305-243-6575
Dr. Bernal-Mizrachi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1999
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1993 - 1996
Universidad del Valle Health SciencesClass of 1989
Certifications & Licensure
FL State Medical License 2016 - 2026
MI State Medical License 2009 - 2019
MO State Medical License 1999 - 2010
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Publications & Presentations
PubMed
- Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion.Valentina Pita-Grisanti, Flavia Leticia Martins Peçanha, Ruy A Louzada, Manuel Blandino-Rosano, Camillo Jaramillo
Diabetes... 2025-11-14 - Functional Domain Mapping of TPO: Insights from Six Variants in Sudanese Kindreds with Congenital Hypothyroidism.Mohammad S Islam, Ruy Andrade Louzada Neto, Jessica Bouviere, Amna E Ahmed, Ernesto Bernal-Mizrachi
The Journal of Clinical Endocrinology and Metabolism. 2025-09-26 - Glycemic Control in Patients with Employer-Sponsored Health Benefits.Judy Z Louie, Charles M Rowland, Dov Shiffman, Rajesh Garg, Ernesto Bernal-Mizrachi
Population Health Management. 2025-02-01
Press Mentions
Miller School of Medicine Diabetes Day: Breakthroughs in Prevention, Treatment and TechnologyNovember 17th, 2025- Miller School Endocrinologists Pursue Comprehensive Understanding of ObesityAugust 6th, 2025
Research Illuminates Potential Pathway to Type 2 DiabetesSeptember 21st, 2017- Join now to see all
Grant Support
- Loss of insulin signaling across functional pancreas compartments as a major pathogenic mechanism underlying diabetic exocrine pancreatopathyUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2024–2028
- mTOR signaling and regulation of alpha-cell mass and functionMIAMI VA HEALTH CARE SYSTEM2016–2028
- mTOR signaling and regulation of alpha-cell mass and functionMIAMI VA HEALTH CARE SYSTEM2016–2028
- Amino acid sensing mechanisms in beta and alpha cellsUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2022–2027
- Role of mTORC1 signaling in type 1 diabetesUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2022–2026
- Nutrient Signals And Programming Of Pancreas DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Akt/Mtor Signaling And Regulation Of Cell Cycle In Beta CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Akt/Mtor Signaling And Regulation Of Cell Cycle In Beta CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2009
- Regulation Of Pancreas Development By P13k/Akt SignalingNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
